Trust CO Of Vermont Incyte Corp Transaction History

Trust CO Of Vermont

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 08, 2024	BUY	$52.16 - $64.19 $260 - $320	5 New	5 $0
Q1 2019 May 01, 2019	SELL	$63.56 - $88.17 $2,860 - $3,967	-45 Closed	0 $0
Q4 2018 Jan 30, 2019	SELL	$58.5 - $69.94 $2,632 - $3,147	-45 Reduced 50.0%	45 $3,000
Q2 2018 Jul 11, 2018	BUY	$60.85 - $83.98 $5,476 - $7,558	90 New	90 $6,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

Stay updated on Trust CO Of Vermont with notifications on news.